Status:
COMPLETED
Dexmedetomidine Improves Recovery After Cranial Aneurysm Surgery
Lead Sponsor:
Zhihong LU
Conditions:
Aneurysm Cerebral
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Dexmedetomidine induces analgesic and sedative effects and is reported to decrease agitation during emergence after general anesthesia in various surgeries. For patients undergoing cranial aneurysm su...
Eligibility Criteria
Inclusion
- patients undergoing cerebral aneurysm embolism under general anesthesia
Exclusion
- patients with bradycardia or atrioventricular heart block
- patients with ASA(American Society of Anesthesiologists) status over 3
- patients with body mass index(BMI)≥30kg/m2
- patients with difficulty in communication
- patients with ruptured aneurysm
- patients suspected or proved to be pregnant
Key Trial Info
Start Date :
January 5 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2020
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03355534
Start Date
January 5 2018
End Date
December 30 2020
Last Update
May 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xijing Hospital
Xi'an, Shaanxi, China, 710032